{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/CLB/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-18T15:52:41.295Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":10169,"canonical_name":"Core Laboratories Inc. /DE/","cik":"0001958086","uei":null,"lei":null,"duns":null,"ticker":"CLB"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":17},"count":17,"timeline":[{"ts":"2026-10-05","kind":"sec.filing","form_type":"4","title":"4 — Core Laboratories Inc. /DE/ — 2026-10-05","url_slug":"/sec/cik-0001958086/4/0001193125-26-413736","accession_number":"0001193125-26-413736","importance":30},{"ts":"2026-08-25","kind":"sec.filing","form_type":"8-K","title":"8-K — Core Laboratories Inc. /DE/ — 2026-08-25","url_slug":"/sec/cik-0001958086/8-k/0001193125-26-365271","accession_number":"0001193125-26-365271","importance":35},{"ts":"2026-08-14","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Core Laboratories Inc. /DE/ — 2026-08-14","url_slug":"/sec/cik-0001958086/schedule-13g-a/0000936753-26-000045","accession_number":"0000936753-26-000045","importance":30},{"ts":"2026-08-06","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Core Laboratories Inc. /DE/ — 2026-08-06","url_slug":"/sec/cik-0001958086/schedule-13g-a/0002012383-26-003225","accession_number":"0002012383-26-003225","importance":30},{"ts":"2026-08-04","kind":"sec.filing","form_type":"4","title":"4 — Core Laboratories Inc. /DE/ — 2026-08-04","url_slug":"/sec/cik-0001958086/4/0001193125-26-331843","accession_number":"0001193125-26-331843","importance":30},{"ts":"2026-08-01","kind":"sec.insider.f","reporter":"Teo Sow Hang","title":"CAO & Treasurer","shares":108,"price_per_share":10.64,"usd_value":1149,"security_title":"Common Stock","importance":15.00114912},{"ts":"2026-08-01","kind":"sec.insider.f","reporter":"Tattoli Mark Damian","title":"SVP, Gen Counsel & Secretary","shares":99,"price_per_share":10.64,"usd_value":1053,"security_title":"Common Stock","importance":15.00105336},{"ts":"2026-08-01","kind":"sec.insider.f","reporter":"Teo Sow Hang","title":"CAO & Treasurer","shares":90,"price_per_share":10.64,"usd_value":958,"security_title":"Common Stock","importance":15.0009576},{"ts":"2026-08-01","kind":"sec.insider.m","reporter":"Tattoli Mark Damian","title":"SVP, Gen Counsel & Secretary","shares":250,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-08-01","kind":"sec.insider.m","reporter":"Teo Sow Hang","title":"CAO & Treasurer","shares":240,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-08-01","kind":"sec.insider.m","reporter":"Teo Sow Hang","title":"CAO & Treasurer","shares":200,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-07-31","kind":"sec.insider.p","reporter":"Bruno Lawrence","title":"Chairman and CEO","shares":5000,"price_per_share":10.78,"usd_value":53900,"security_title":"Common Stock","importance":50.0539},{"ts":"2026-07-30","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Core Laboratories Inc. /DE/ — 2026-07-30","url_slug":"/sec/cik-0001958086/10-q/0001193125-26-326345","accession_number":"0001193125-26-326345","importance":45},{"ts":"2026-07-29","kind":"sec.filing","form_type":"8-K","title":"8-K — Core Laboratories Inc. /DE/ — 2026-07-29","url_slug":"/sec/cik-0001958086/8-k/0001193125-26-324101","accession_number":"0001193125-26-324101","importance":35},{"ts":"2026-06-29","kind":"sec.filing","form_type":"11-K","title":"11-K — Core Laboratories Inc. /DE/ — 2026-06-29","url_slug":"/sec/cik-0001958086/11-k/0001193125-26-287703","accession_number":"0001193125-26-287703","importance":30},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SD","title":"SD — Core Laboratories Inc. /DE/ — 2026-05-15","url_slug":"/sec/cik-0001958086/sd/0001193125-26-226332","accession_number":"0001193125-26-226332","importance":30},{"ts":"2026-05-13","kind":"sec.filing","form_type":"8-K","title":"8-K — Core Laboratories Inc. /DE/ — 2026-05-13","url_slug":"/sec/cik-0001958086/8-k/0001193125-26-221857","accession_number":"0001193125-26-221857","importance":35}]}